Maternal serum IGF-1, IGFBP-1 and 3, and placental growth hormone (cas 109675-94-7) at 20 weeks’ gestation in pregnancies complicated by preeclampsia

Add time:07/23/2019    Source:sciencedirect.com

ObjectiveTo investigate whether maternal serum concentrations of placental growth hormone (cas 109675-94-7) (GH-V), insulin-like growth factor (IGF) 1 and 2, and IGF binding proteins (IGFBP) 1 and 3 were altered in pregnancies complicated by later preeclampsia (PE).

We also recommend Trading Suppliers and Manufacturers of placental growth hormone (cas 109675-94-7). Pls Click Website Link as below: cas 109675-94-7 suppliers

Prev:Human placental growth hormone (cas 109675-94-7) in ectopic pregnancy: Detection in maternal blood, immunohistochemistry and potential clinical implication
Next:Complexes of Cu(II) with 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-piperazine (prazosin): synthesis, properties, crystal structure)